Although dialysis provider DaVita Inc. has taken major financial hits this year, including a $383.5 million jury award in response to wrongful death lawsuits, it still rakes in profits. The company faces its biggest threat next month, when California voters weigh in on a ballot initiative that could force it to leave the state.
A California college professor never imagined that trying to figure out what was causing her rash could add up to such a huge bill.
Over the past five months, the Trump administration has proposed a series of reforms to lower the cost of prescription drugs.
Idaho is one of four conservative states where voters next month will determine whether to buck the GOP’s resistance to the Affordable Care Act and implement or renew its expansion of Medicaid to adults.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Anna Edney of Bloomberg News, Kimberly Leonard of the Washington Examiner and Alice Ollstein of Politico discuss a flurry of proposals from the Trump administration on prices Medicare pays for drugs and the Affordable Care Act.
The drop in the number of people enrolled in the federal-state program for low-income residents is the first since 2007.
The state-federal health insurance program is more popular than ever. Now, states that want to expand eligibility are devising new strategies to pay for it — creating, in many red states, a significant political challenge.
The front-runner in the California governor’s race, known for his political audacity, has officially endorsed the controversial move to create one public insurance program for all Californians. Yet he also faces formidable challenges, and liberal critics fear he’ll retreat.
This gap in the 2010 health law means health insurance remains unaffordable for millions of Americans. For now, relief is hard to come by.
As rates of sexually transmitted diseases surge, public health officials want physicians to step up screening and treatment of patients.
